e-learning
resources
Paris 2018
Tuesday, 18.09.2018
COPD exacerbations and bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
M. Arjomandi (San Francisco, United States of America), S. Zeng (San Francisco, United States of America), C. Huang (San Francisco, United States of America), P. Blanc (San Francisco, United States of America)
Source:
International Congress 2018 – COPD exacerbations and bronchiectasis
Session:
COPD exacerbations and bronchiectasis
Session type:
Thematic Poster
Number:
4084
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arjomandi (San Francisco, United States of America), S. Zeng (San Francisco, United States of America), C. Huang (San Francisco, United States of America), P. Blanc (San Francisco, United States of America). Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD. 4084
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Influence of smoking on reversibility of obstruction in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 328s
Year: 2002
Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Smoking, asthma, chronic airflow obstruction and COPD
Source: Eur Respir J 2015; 45: 586-588
Year: 2015
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Late Breaking Abstract: Tiotropium improves lung function in patients with severe uncontrolled asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Late Breaking Abstract - Indacaterol/glycopyrronium versus salmeterol/fluticasone in chronic obstructive pulmonary disease: a meta-analysis on the protection against the risk of exacerbation
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Late Breaking Abstract - Diagnosis of chronic obstructive pulmonary disease (COPD) exacerbations using a smartphone-based, cough-centred algorithm
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Degree of airflow obstruction and incidence of lung cancer: a beneficial paradox?
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD
Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections
Year: 2021
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Clinically remitted childhood asthma is a risk factor for airflow obstruction in middle-aged adults
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe.
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Do COPD patients with only mild-to-moderate airflow obstruction present with endothelial dysfunction?
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Late Breaking Abstract - Does medication exacerbate comorbidities in chronic obstructive pulmonary disease? A prevalence study of neuroleptic intake
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - Silent exacerbations: underreporting of COPD exacerbations in Poland
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept